Rising Healthcare Expenditure and Worldwide Diseases Prevalence to Boost Hospital Pharmaceutical Drugs Market to USD 235 Billion by 2020 - iHealthcareAnalyst, Inc.
Hospital Pharmaceutical Drugs Market – Global Hospital-Associated Indications and Therapeutic Drugs Analysis and Forecast 2013-2020
Maryland Heights, MO, August 07, 2016 --(PR.com)-- According to a new market research report published by iHealthcareAnalyst, Inc., Hospital Pharmaceutical Drugs Market – Global Hospital-Associated Indications and Therapeutic Drugs Analysis and Forecast 2013-2020, the global medical transcription services market is estimated to reach USD 235 Billion in 2020, expanding at a CAGR of 2.8% from 2016 to 2020.
Visit the Hospital Pharmaceutical Drugs Market – Global Hospital-Associated Indications and Therapeutic Drugs Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/hospital-pharmaceuticals-market/
The global hospital pharmaceutical drugs market report estimates the market size (Revenue USD million - 2013 to 2020) for key market segments based on the indications and therapeutic applications in cardiology, oncology, nephrology and urology, pain and infection categories, and forecasts growth trends (CAGR% - 2016 to 2020). The indication types includes coronary heart diseases, heart failure, high blood pressure, stroke, breast cancer, colorectal cancer, lung cancer, prostate cancer, acute kidney failure, chronic kidney diseases, diabetes, glomerular diseases, Alzheimer’s disease, epilepsy, multiple sclerosis, Parkinson’s disease, cancer pain, fibromyalgia, neuropathic pain, osteoarthritis, rheumatoid arthritis, amoebiasis, candida infection, tuberculosis, fungal meningitis, hepatitis A, hepatitis B, pneumonia, shigellosis; while therapeutics include anti-adrenergic drugs, anti-arrhythmic drugs, calcium channel blockers, diuretic drugs, 5-alpha reductase inhibitors, alkylating agents, anticholinergic drugs, anti-hypertensive agents, anti-metabolites, diuretic agents, hormonal agents, immunomodulation agents, miscellaneous drugs, phosphate binders, neurology, anti-anxiety agents, antidepressant drugs, anti-migraine drugs, anti-psychotic drugs, anesthetic drugs, anticonvulsant drugs, non-narcotics analgesic drugs, non-steroidal anti-inflammatory drugs, opioids, antibacterial drugs, antifungal drugs, anti-parasite drugs, and antiviral drugs. It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends.
The global hospital pharmaceutical drugs market is segmented as:
1. Indication Type
1.1. Cardiology
1.1.1.Coronary Heart Diseases
1.1.2. Heart Failure
1.1.3. High Blood Pressure
1.1.4. Stroke
1.1.5. Others
1.2. Oncology
1.2.1. Breast Cancer
1.2.2. Colorectal Cancer
1.2.3. Lung Cancer
1.2.4. Prostate Cancer
1.2.5. Others
1.3. Nephrology and Urology
1.3.1. Acute Kidney Failure
1.3.2. Chronic Kidney Diseases
1.3.3. Diabetes
1.3.4. Glomerular Diseases
1.3.5. Others
1.4.Neurology
1.4.1. Alzheimer’s Disease
1.4.2. Epilepsy
1.4.3. Multiple Sclerosis
1.4.4. Parkinson’s Disease
1.4.5. Others
1.5. Pain
1.5.1. Cancer Pain
1.5.2. Fibromyalgia
1.5.3. Neuropathic Pain
1.5.4. Osteoarthritis
1.5.5. Rheumatoid Arthritis
1.6.Infection
1.6.1. Amoebiasis
1.6.2. Candida Infection
1.6.3. Tuberculosis
1.6.4. Fungal Meningitis
1.6.5. Hepatitis A
1.6.6. Hepatitis B
1.6.7. Pneumonia
1.6.8. Shigellosis
1.6.9. Others
2. Therapeutic Application
2.1. Cardiology
2.1.1. Anti-Adrenergic Drugs
2.1.2. Anti-Arrhythmic Drugs
2.1.3. Calcium Channel Blockers
2.1.4. Diuretic Drugs
2.1.5. Others
2.2. Oncology
2.2.1. 5-Alpha Reductase Inhibitors
2.2.2. Alkylating Agents
2.2.3. Anticholinergic Drugs
2.2.4. Anti-Hypertensive Agents
2.2.5. Anti-Metabolites
2.2.6. Diuretic Agents
2.2.7. Hormonal Agents
2.2.8. Immunomodulation Agents
2.2.9. Miscellaneous Drugs
2.3. Nephrology and Urology
2.3.1. Phosphate Binders
2.3.2. Neurology
2.3.3. Anti-Anxiety Agents
2.3.4. Antidepressant Drugs
2.3.5. Anti-Migraine Drugs
2.3.6. Anti-Psychotic Drugs
2.4. Pain
2.4.1. Anesthetic Drugs
2.4.2. Anticonvulsant Drugs
2.4.3. Non-Narcotics Analgesic Drugs
2.4.4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2.4.5. Opioids
2.5. Infection
2.5.1. Antibacterial Drugs
2.5.2. Antifungal Drugs
2.5.3. Antiparasite Drugs
2.5.4. Antiviral Drugs
3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World
4. Company Profiles
4.1. AstraZeneca plc.
4.2. Bayer AG
4.3. Bristol-Myers Squibb Company
4.4. Eli Lilly and Company
4.5. GlaxoSmithKline plc
4.6. Johnson & Johnson
4.7. Merck & Co., Inc.
4.8. Novartis AG
4.9. Pfizer, Inc.
4.10. Sanofi-Aventis
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Visit the Hospital Pharmaceutical Drugs Market – Global Hospital-Associated Indications and Therapeutic Drugs Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/hospital-pharmaceuticals-market/
The global hospital pharmaceutical drugs market report estimates the market size (Revenue USD million - 2013 to 2020) for key market segments based on the indications and therapeutic applications in cardiology, oncology, nephrology and urology, pain and infection categories, and forecasts growth trends (CAGR% - 2016 to 2020). The indication types includes coronary heart diseases, heart failure, high blood pressure, stroke, breast cancer, colorectal cancer, lung cancer, prostate cancer, acute kidney failure, chronic kidney diseases, diabetes, glomerular diseases, Alzheimer’s disease, epilepsy, multiple sclerosis, Parkinson’s disease, cancer pain, fibromyalgia, neuropathic pain, osteoarthritis, rheumatoid arthritis, amoebiasis, candida infection, tuberculosis, fungal meningitis, hepatitis A, hepatitis B, pneumonia, shigellosis; while therapeutics include anti-adrenergic drugs, anti-arrhythmic drugs, calcium channel blockers, diuretic drugs, 5-alpha reductase inhibitors, alkylating agents, anticholinergic drugs, anti-hypertensive agents, anti-metabolites, diuretic agents, hormonal agents, immunomodulation agents, miscellaneous drugs, phosphate binders, neurology, anti-anxiety agents, antidepressant drugs, anti-migraine drugs, anti-psychotic drugs, anesthetic drugs, anticonvulsant drugs, non-narcotics analgesic drugs, non-steroidal anti-inflammatory drugs, opioids, antibacterial drugs, antifungal drugs, anti-parasite drugs, and antiviral drugs. It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends.
The global hospital pharmaceutical drugs market is segmented as:
1. Indication Type
1.1. Cardiology
1.1.1.Coronary Heart Diseases
1.1.2. Heart Failure
1.1.3. High Blood Pressure
1.1.4. Stroke
1.1.5. Others
1.2. Oncology
1.2.1. Breast Cancer
1.2.2. Colorectal Cancer
1.2.3. Lung Cancer
1.2.4. Prostate Cancer
1.2.5. Others
1.3. Nephrology and Urology
1.3.1. Acute Kidney Failure
1.3.2. Chronic Kidney Diseases
1.3.3. Diabetes
1.3.4. Glomerular Diseases
1.3.5. Others
1.4.Neurology
1.4.1. Alzheimer’s Disease
1.4.2. Epilepsy
1.4.3. Multiple Sclerosis
1.4.4. Parkinson’s Disease
1.4.5. Others
1.5. Pain
1.5.1. Cancer Pain
1.5.2. Fibromyalgia
1.5.3. Neuropathic Pain
1.5.4. Osteoarthritis
1.5.5. Rheumatoid Arthritis
1.6.Infection
1.6.1. Amoebiasis
1.6.2. Candida Infection
1.6.3. Tuberculosis
1.6.4. Fungal Meningitis
1.6.5. Hepatitis A
1.6.6. Hepatitis B
1.6.7. Pneumonia
1.6.8. Shigellosis
1.6.9. Others
2. Therapeutic Application
2.1. Cardiology
2.1.1. Anti-Adrenergic Drugs
2.1.2. Anti-Arrhythmic Drugs
2.1.3. Calcium Channel Blockers
2.1.4. Diuretic Drugs
2.1.5. Others
2.2. Oncology
2.2.1. 5-Alpha Reductase Inhibitors
2.2.2. Alkylating Agents
2.2.3. Anticholinergic Drugs
2.2.4. Anti-Hypertensive Agents
2.2.5. Anti-Metabolites
2.2.6. Diuretic Agents
2.2.7. Hormonal Agents
2.2.8. Immunomodulation Agents
2.2.9. Miscellaneous Drugs
2.3. Nephrology and Urology
2.3.1. Phosphate Binders
2.3.2. Neurology
2.3.3. Anti-Anxiety Agents
2.3.4. Antidepressant Drugs
2.3.5. Anti-Migraine Drugs
2.3.6. Anti-Psychotic Drugs
2.4. Pain
2.4.1. Anesthetic Drugs
2.4.2. Anticonvulsant Drugs
2.4.3. Non-Narcotics Analgesic Drugs
2.4.4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2.4.5. Opioids
2.5. Infection
2.5.1. Antibacterial Drugs
2.5.2. Antifungal Drugs
2.5.3. Antiparasite Drugs
2.5.4. Antiviral Drugs
3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World
4. Company Profiles
4.1. AstraZeneca plc.
4.2. Bayer AG
4.3. Bristol-Myers Squibb Company
4.4. Eli Lilly and Company
4.5. GlaxoSmithKline plc
4.6. Johnson & Johnson
4.7. Merck & Co., Inc.
4.8. Novartis AG
4.9. Pfizer, Inc.
4.10. Sanofi-Aventis
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories